Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill
| Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill |
| Pubbl/distr/stampa | Malden, Mass., : BMJ Books/Blackwell Pub., 2004 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina |
362.17/82
362.1782 |
| Altri autori (Persone) |
FreemantleNick
HillSuzanne |
| Soggetto topico | Pharmaceutical policy |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-280-19728-5
9786610197286 0-470-79102-0 0-470-99471-1 1-4051-4097-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Development of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit Rägo -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] --
Relationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.]. |
| Record Nr. | UNINA-9910143266303321 |
| Malden, Mass., : BMJ Books/Blackwell Pub., 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill
| Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill |
| Pubbl/distr/stampa | Malden, Mass., : BMJ Books/Blackwell Pub., 2004 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina |
362.17/82
362.1782 |
| Altri autori (Persone) |
FreemantleNick
HillSuzanne |
| Soggetto topico | Pharmaceutical policy |
| ISBN |
1-280-19728-5
9786610197286 0-470-79102-0 0-470-99471-1 1-4051-4097-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Development of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit Rägo -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] --
Relationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.]. |
| Record Nr. | UNISA-996211169103316 |
| Malden, Mass., : BMJ Books/Blackwell Pub., 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill
| Evaluating pharmaceuticals for health policy and reimbursement [[electronic resource] /] / edited by Nick Freemantle and Suzanne Hill |
| Pubbl/distr/stampa | Malden, Mass., : BMJ Books/Blackwell Pub., 2004 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina |
362.17/82
362.1782 |
| Altri autori (Persone) |
FreemantleNick
HillSuzanne |
| Soggetto topico | Pharmaceutical policy |
| ISBN |
1-280-19728-5
9786610197286 0-470-79102-0 0-470-99471-1 1-4051-4097-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Development of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit Rägo -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] --
Relationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.]. |
| Record Nr. | UNINA-9910831053403321 |
| Malden, Mass., : BMJ Books/Blackwell Pub., 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Evaluating pharmaceuticals for health policy and reimbursement / / edited by Nick Freemantle and Suzanne Hill
| Evaluating pharmaceuticals for health policy and reimbursement / / edited by Nick Freemantle and Suzanne Hill |
| Pubbl/distr/stampa | Malden, Mass., : BMJ Books/Blackwell Pub., 2004 |
| Descrizione fisica | 1 online resource (280 p.) |
| Disciplina | 362.17/82 |
| Altri autori (Persone) |
FreemantleNick
HillSuzanne |
| Soggetto topico | Pharmaceutical policy |
| ISBN |
1-280-19728-5
9786610197286 0-470-79102-0 0-470-99471-1 1-4051-4097-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Development of marketing authorisation procedures for pharmaceuticals / Alar Irs, Truus Janse de Hoog, Lembit Rago -- Interpreting clinical evidence / Nick Freemantle ... [et al.] -- International pharmaceutical policy: health creation or wealth creation? / Karen Bloor, Alan Maynard -- Development of fourth hurdle policies around the world / Rod S. Taylor ... [et al.] -- Economic modelling in drug reimbursement / Glenn Salkeld, Nick Freemantle, Bernie O'Brien -- Priority setting in health care: matching decision criteria with policy objectives / Gina Brinsmead, Alan Williams -- Tensions in licensing and reimbursement decisions: the case of riluzole for amyotrophic lateral sclerosis / Stirling Bryan ... [et al.] --
Relationships between stakeholders: managing the war of words / Suzanne Hill, Kees de Joncheere -- Medicine and the media: good information or misleading hype? / Ray Moynihan, Lisa M. Schwartz, Steven Woloshin -- How to promote quality use of cost-effective medicines / Hans Hogerzeil, Kathleen Holloway -- Using economic evaluation to inform health policy and reimbursement: making it happen and making it sustainable / Andrew Mitchell -- Pricing of pharmaceuticals / David Newby, Andrew Creese, Alan Stevens -- Evaluating pharmaceuticals for health policy in low and middle income country settings / Andrew Creese ... [et al.]. |
| Record Nr. | UNINA-9910877810603321 |
| Malden, Mass., : BMJ Books/Blackwell Pub., 2004 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Optimizing Treatment for Children in the Developing World / / edited by Stuart MacLeod, Suzanne Hill, Gideon Koren, Anders Rane
| Optimizing Treatment for Children in the Developing World / / edited by Stuart MacLeod, Suzanne Hill, Gideon Koren, Anders Rane |
| Edizione | [1st ed. 2015.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 |
| Descrizione fisica | 1 online resource (333 p.) |
| Disciplina |
610
615.1 618.92 |
| Soggetto topico |
Pediatrics
General practice (Medicine) Pharmacotherapy General Practice / Family Medicine |
| ISBN | 3-319-15750-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Foreword -- Shifting demographics and regional disparities -- Access issues -- Ending stockouts -- Improved formulations and optimal dosing -- Deficient and counterfeit products -- Knowledge gaps in pregnancy and lactation -- Factors enabling improved therapy -- Regulatory science -- Human resource planning -- Information and communications technology -- Pharmaceutical care -- Networks (GRIP, INRUD, MSH, PTN,MYCRN, IABMC) -- Research challenges -- Research standards for clinical trials in low and middle income countries -- Innovative appropriate trial methods -- Nutrition/micronutrients -- Impact on therapeutic outcomes -- Drug safety and pharmaco-epidemiology -- Personalized treatment and Pharmacogenomics -- Neglected diseases -- Health outcomes and economics -- Enhanced industry engagement -- Incorporating social science perspectives -- Clinical settings -- Treatment in the community -- Treatment at the district hospital level -- Care of the critically ill child -- Palliative care and pain management. – Conclusion -- The light at the end of the tunnel: future directions. |
| Record Nr. | UNINA-9910300238903321 |
| Cham : , : Springer International Publishing : , : Imprint : Adis, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
WHO model formulary 2008 [[electronic resource] /] / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill]
| WHO model formulary 2008 [[electronic resource] /] / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2009 |
| Descrizione fisica | 1 online resource (645 p.) |
| Disciplina | 615.13 |
| Altri autori (Persone) |
StuartMark C
KouimtziMaria HillSuzanne |
| Soggetto topico |
Medicine
Drugs - Prescribing |
| Soggetto genere / forma | Electronic books. |
| ISBN |
1-282-45614-8
9786612456145 92-4-068424-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
WHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes
12. Cardiovascular medicines13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals Appendix 1: InteractionsAppendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index |
| Record Nr. | UNINA-9910457116103321 |
| Geneva, : World Health Organization, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
WHO model formulary 2008 / / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill]
| WHO model formulary 2008 / / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill] |
| Pubbl/distr/stampa | Geneva : , : World Health Organization, , 2009 |
| Descrizione fisica | 1 online resource (645 pages) |
| Disciplina | 615.13 |
| Altri autori (Persone) |
StuartMark C
KouimtziMaria HillSuzanne |
| Soggetto topico |
Medicine
Drugs - Prescribing |
| ISBN |
1-282-45614-8
9786612456145 92-4-068424-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
WHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes
12. Cardiovascular medicines; 13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals; Appendix 1: Interactions; Appendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index |
| Record Nr. | UNINA-9910781057303321 |
| Geneva : , : World Health Organization, , 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
WHO model formulary 2008 / / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill]
| WHO model formulary 2008 / / [edited by Mark C. Stuart, Maria Kouimtzi, Suzanne R. Hill] |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Geneva, : World Health Organization, 2009 |
| Descrizione fisica | 1 online resource (645 pages) |
| Disciplina | 615.13 |
| Altri autori (Persone) |
StuartMark C
KouimtziMaria HillSuzanne |
| Soggetto topico |
Medicine
Drugs - Prescribing |
| ISBN |
1-282-45614-8
9786612456145 92-4-068424-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
WHO MODEL FORMULARY 2008; Title Page; Contents; Abbreviations; Introduction; Changes to the WHO Model List of Essential; General advice to prescribers; 1. Anaesthetics; 2. Analgesics, antipyretics, non-steroidal anti-inflammatory; 3. Antiallergics and medicines used in anaphylaxis; 4. Antidotes and other substances used in poisonings; 5. Anticonvulsants/antiepileptics; 6. Anti-infective medicines; 7. Antimigraine medicines; 8. Antineoplastic, immunosuppressives and medicines used; 9. Antiparkinsonism medicines; 10. Medicines affecting the blood; 11. Blood products and plasma substitutes
12. Cardiovascular medicines; 13. Dermatological medicines (topical); 14. Diagnostic agents; 15. Disinfectants and antiseptics; 16. Diuretics; 17. Gastrointestinal medicines; 18. Hormones, other endocrine medicines and contraceptives; 19. Immunologicals; 20. Muscle relaxants (peripherally-acting) and cholinesterase; 21. Ophthalmological preparations; 22. Oxytocics and antioxytocics; 23. Peritoneal dialysis solution; 24. Psychotherapeutic medicines; 25. Medicines acting on the respiratory tract; 26. Solutions correcting water, electrolyte and acid-base; 27. Vitamins and minerals; Appendix 1: Interactions; Appendix 2: Pregnancy; Appendix 3: Breastfeeding; Appendix 4: Renal impairment; Appendix 5: Hepatic impairment; Index |
| Record Nr. | UNINA-9910815939903321 |
| Geneva, : World Health Organization, 2009 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||